Real-time enrollment status for this stage iii lung cancer ajcc v8 clinical trial
Current Status
Recruiting
Checked: October 18, 2026 at 12:08 AM UTC
| NCT Number | NCT04892953 |
| Recruiting Status | Recruiting |
| Condition | Stage III Lung Cancer AJCC v8 |
| Phase | PHASE2 |
| Target Enrollment | 51 participants |
| Active Locations | 1 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | September 3, 2026 (Sep 3, 2026) |
As of October 18, 2026: Clinical trial NCT04892953 is currently recruiting participants. This phase2 study for stage iii lung cancer ajcc v8 is actively seeking new participants at 1 location across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04892953 is actively recruiting participants as of October 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04892953 was last updated Sep 3, 2026 (September 3, 2026). HelloStudys verifies this status automatically.